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Background and Objective: Lipopolysaccharide from gram-negative bacteria is
one of the microbial-associated molecular patterns that initiate the immune/
inflammatory response, leading to the tissue destruction observed in periodontitis.
The aim of this study was to evaluate the role of the p38 mitogen-activated protein
kinase (MAPK) signaling pathway in lipopolysaccharide-induced receptor acti-
vator of nuclear factor-jB ligand (RANKL) expression by murine periodontal
ligament cells.
Material and Methods: Expression of RANKL and osteoprotegerin mRNA was
studied by reverse transcription-polymerase chain reaction upon stimulation
with lipopolysaccharide from Escherichia coli and Aggregatibacter actinomyce-
temcomitans. The biochemical inhibitor SB203580 was used to evaluate the
contribution of the p38 MAPK signaling pathway to lipopolysaccharide-
induced RANKL and osteoprotegerin expression. Stable cell lines expressing
dominant-negative forms of MAPK kinase (MKK)-3 and MKK6 were gener-
ated to confirm the role of the p38 MAPK pathway. An osteoclastogenesis
assay using a coculture model of the murine monocytic cell line RAW 264.7
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Coupled bone turnover is a tightly
regulated process balanced by osteo-
blasts and osteoclasts. Uncoupling
leads towards net bone loss associated
with several inflammatory bone dis-
eases, including periodontal diseases.
Initiated by pro-inflammatory stimuli
(such as lipopolysaccharide) originating
from dental biofilm-associated bacteria,
molecular events leading towards
periodontal tissue and bone destruc-
tion are set in motion in the periodon-
tal microenvironment. Fundamental
aspects of the bone resorption process
have been discovered in recent years
following identification of receptor
activator of nuclear factor-jB ligand
(RANKL) and its decoy receptor,
osteoprotegerin. These cytokines con-
stitute the current paradigm for the
processes of osteoclast differentiation
and activation. The induction of cou-
pled bone resorption by inflammatory
cytokines involves increased RANKL
expression on various cell types, inclu-
ding osteoblastic cells, bone marrow
stromal cells, endothelial cells, mono-
nuclear cells and periodontal ligament
fibroblasts, which activate receptor
activator of nuclear factor-jB (RANK)
on pre-osteoclastic cells to induce
osteoclastogenesis and subsequent bone
resorption (1–5).
The unique location of the perio-
dontal ligament between two mineral-
ized tissues, cementum and alveolar
bone, suggests that it may have an
essential role in periodontal home-
ostasis. This assumption is supported
by classical histological studies on
periodontal regeneration (6). Thus,
alveolar bone formation and resorp-
tion in the periodontium seems to be
largely controlled by cells in the
periodontal ligament, as also suppor-
ted by studies on orthodontic move-
ment of teeth where RANKL/
osteoprotegerin expression was shown
to be involved (7). Even though
periodontal ligament cells were initially
considered as inhibitors of osteo-
clastogenesis and shown to express
osteoprotegerin (8), these cells were
demonstrated to express RANKL in
situations associated with resorption of
mineralized tissue, including physio-
logic permanent tooth eruption and
deciduous tooth root resorption (9–
11). Specifically, periodontal ligament
cells were shown to form bone-like
tissues (12,13) and also to express
RANKL and osteoprotegerin mRNA
after stimulation with di-hydroxyl
vitamin D3, prostaglandin E2, inter-
leukin-1b, interleukin-1a and mechan-
ical stress (10,14–18).
The RANKL/RANK/osteoproteg-
erin system as a key mediator of bone
loss in periodontal disease comes from
recent in vivo studies, both in animal
models (19,20) and in humans (21,22),
demonstrating the expression of
higher levels of RANKL and lower
levels of osteoprotegerin in the pres-
ence of alveolar bone resorption (23).
Even though numerous studies have
demonstrated that bacterial lipopoly-
saccharide has bone-resorbing capacity
in vitro and in vivo (24–27), controversy
still exists regarding the potency of the
different pathogen-associated molecu-
lar patterns in inducing RANKL
expression. Recently, periodontal liga-
ment fibroblasts have been shown to
produce RANKL mRNA induced by
interleukin-1a indirectly through pro-
staglandinE2 induction, which involved
extracellular signal-regulated kinase
(ERK) mitogen-activated protein
kinase (MAPK) signaling (15). Also
recently, all three MAPKs (ERK, c-Jun
N-terminal kinase and p38) were
shown to be involved in interleukin-1a-
induced RANKL expression by human
periodontal ligament fibroblasts (28).
Conversely, RANKL expression by
Porphyromonas gingivalis-infected ost-
eoblasts did not involve p38 or ERK
MAPKs or phosphoinositol-3 kinase
pathways (29). In fact, these authors
(29) reported that lipopolysaccharide
from P. gingivalis was not respon-
sible for the induction of RANKL
in infected osteoblasts, which suggests
that the Toll-like receptor 2 (TLR-2)
signaling pathway may not be
involved in RANKL expression by
these cells.
There is a lack of information on
the signaling pathways involved in
lipopolysaccharide-induced RANKL
was used to determine if osteoclast differentiation induced by lipopoly-
saccharide-stimulated periodontal ligament was correlated with RANKL
expression.
Results: Inhibiting p38 MAPK prior to lipopolysaccharide stimulation resulted in
a significant decrease of RANKL mRNA expression. Osteoprotegerin mRNA
expression was not affected by lipopolysaccharide or p38 MAPK. Lipopolysac-
charide-stimulated periodontal ligament cells increased osteoclast differentiation,
an effect that was completely blocked by osteoprotegerin and significantly
decreased by inhibition of MKK3 and MKK6, upstream activators of p38
MAPK. Conditioned medium from murine periodontal ligament cultures did not
increase osteoclast differentiation, indicating that periodontal ligament cells pro-
duced membrane-bound RANKL.
Conclusion: Lipopolysaccharide resulted in a significant increase of RANKL in
periodontal ligament cells. The p38 MAPK pathway is required for lipopolysac-
charide-induced membrane-bound RANKL expression in these cells.
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expression by periodontal ligament
fibroblasts. As these cells may play an
important role on alveolar bone
resorption, both during periodontal
disease and orthodontic movement,
understanding the signaling pathways
involved may provide critical informa-
tion towards alternative therapeutic
strategies for the control of alveolar
bone resorption process. Recent data
from our group supports the role of
novel therapeutics, which blocks p38
signaling in preventing alveolar bone
loss induced by lipopolysaccharide
in vivo (3). Considering that RANKL
expression may require different signa-
ling pathways depending on the nature
of extracellular stimulation and also on
the cell type, in this study we examined
the role of p38 MAPK signaling on
lipopolysaccharide-induced RANKL




Mouse periodontal ligament fibro-
blasts, immortalized with simian virus
40 large T antigen, were obtained from
Dr Martha Somerman (University of
Washington, Seattle, WA, USA).
These cells were cultured in Dulbecco’s
modified Eagle’s minimal essential
medium supplemented with 100 IU/
mL of penicillin, 100 lg/mL of strep-
tomycin and 10% heat-inactivated fe-
tal bovine serum, and maintained in a
humidified atmosphere at 37C and
5% CO2. Mouse periodontal ligament
cells used were previously character-
ized for the expression of genes nor-
mally expressed by primary
periodontal ligament cells, including
bone sialoprotein, osteopontin, osteo-
calcin and type I collagen (30). Unless
noted otherwise, all tissue culture rea-
gents were obtained from Invitrogen
(Carlsbad, CA, USA). Lipopolysac-
charide from Escherichia coli (serotype
0127:B8) was purchased from Sigma-
Aldrich (St Louis, MO, USA) and
Aggregatibacter actinomycetemcomi-
tans (formerly known as Actinobacillus
actinomycetemcomitans) lipopolysac-
charide was extracted from A. actino-
mycetemcomitans strain Y4 (serotype
B) by the hot phenol-water method, as
described previously (23,31). A. actino
mycetemcomitans lipopolysaccharide
used in the present study was recently
characterized during other studies car-
ried out by our laboratory group (23).
Both E. coli and A. actinomycetem-
comitans lipopolysaccharide were dilu-
ted in serum-free defined culture
medium (Opti-MEM; Invitrogen) to
1 mg/mL. The biochemical inhibitor
SB203580 was from Calbiochem (San
Diego, CA, USA) and RANKL and
osteoprotegerin recombinant proteins
were from R & D systems (Minnea-
polis, MN, USA). Mouse RANKL
monoclonal antibody was purchased
from Stress Gen (Ann Arbor, MI,
USA), and monoclonal glyceralde-
hyde-3-phosphate dehydrogenase anti-
body was from Chemicon (Temecula,
CA, USA). The absence of protein in
A. actinomycetemcomitans lipopoly-
saccharide preparations was checked
by polyacrylamide gel electrophoresis
of extract samples and subsequent
staining with silver nitrate and Coo-
massie Blue, and confirmed by spec-
trophotometry (< 0.001% nucleic
acid) and by a microassay for protein
quantification (cat. no 500–0002;
Bio-Rad Laboratory (Hercules, CA,
USA)) based on the Bradford method
(lower limit of detection: 1.2 lg/mL).
Dominant-negative genetic constructs
of mutated MAP kinase kinase-3 and
MAP kinase kinase-6 were obtained
from J. Han (Scripps Institute, La
Jolla, CA, USA). Stable cell lines were
prepared as described previously (3).
Briefly, after cotransfection of the
overexpression construct and of an
empty vector including resistance to
gentamycin, selection was carried out
for several weeks in medium contain-
ing 800 lg/mL of Geneticyn (Invitro-
gen Corp.) and a number of clones
were screened by western blot to ana-
lyse the expected changes on expres-





reaction (RT-PCR) was used to evalu-
ate mRNA expression, as described
recently (3). Briefly, total RNA was
harvested using Trizol (Invitrogen)
reagent according to the manufac-
turer’s instructions. Complementary
DNA was synthesized by reverse tran-
scription of 500 ng of total RNA using
2.5 lM Oligo (dT) 16 primers and
1.25 U/lL of Moloney murine leuke-
mia virus reverse transcriptase in the
presence of 5.5 mM MgCl2, 2 mM
dNTPs and 0.4 U/lL of RNAse
inhibitor, according to the manufac-
turer’s protocol (Applied Biosystems
(Foster City, CA, USA)). Two micro-
litres of the RT reaction product was
used in a PCR reaction mix of 25 lL
total volume. The primer pair used
for RANKL (accession no.:









enase (accession no.: NM002046) was:
sense 5¢-CACCATGGAGAAGGCC-
GGGG-3¢; antisense 5¢-GACGGA-
CACATTGGGGTAG-3¢. A total of
50 pmol/lL of each primer was used in
the PCR reactions, yielding products
of 467, 503 and 418 bp for RANKL,
osteoprotegerin and glyceraldehyde-3-
phosphate dehydrogenase, respect-
ively. Taq DNA polymerase and other
PCR reagents were purchased from
Invitrogen and the conditions for
RANKL and osteoprotegerin were 35
cycles (32 cycles for osteoprotegerin) of
94C for 1 min, 56C for 1 min, 72C
for 2 min and a final extension step at
72C for 10 min in the presence of
2.5 mM MgCl2, whereas for glyceral-
dehyde-3-phosphate dehydrogenase
the conditions were 25 cycles of 94C
for 1 min, 52C for 1 min, 72C for
2 min and a final extension step at
72C for 10 min in the presence of
1.5 mM MgCl2. PCR products were
resolved in 1.5% agarose gels, stained
with 0.5 lg/mL of ethidium bromide.
The images and densitometric meas-
urements were obtained with a digital
documentation system (Gel Doc XR;
Bio-Rad (Hercules, CA, USA)). The
quantity of RANKL and osteoproteg-
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erin mRNA in each sample was sub-
sequently normalized to the quantity of
glyceraldehyde-3-phosphate dehydrog-
enase mRNA and expressed as fold
change over the unstimulated control
using MOLECULAR ANALYST software
(version 4.5.2; Bio-Rad). The fold
change on the expression of RANKL
was divided by the fold change on




A total of 5 · 104 periodontal ligament
cells were grown for 24 h in each well
of six-well plates, de-induced by incu-
bation for 12 h in culture medium
containing 0.3% fetal bovine serum
and stimulated with either E. coli or
A. actinomycetemcomitans lipopoly-
saccharide for 72 h, both with and
without a 30-min pretreatment with
10 lM SB203580. Whole-cell lysates
were harvested by scraping the perio-
dontal ligament cells with sodium
dodecyl sulfate sample buffer (62.5 mM
Tris HCl buffer, pH 6.8, 10% glycerol,
50 mM dithiothreitol, 2% sodium
dodecyl sulfate, 0.01% bromophenol
blue) on ice, followed by sonication
for 10 s and heat-denaturation at 95C
for 5 min. Total protein content
was quantified by a Bradford-based
microassay. For western blotting,
30 lg of total proteins were separated
on 10% Tris-HCl polyacrylamide gels
run at 100 V for 60 min and subse-
quently electrotransferred for another
60 min at 110 mA in a semidry appar-
atus to nitrocellulose membranes. The
membranes were blocked (Tris-buf-
fered saline with 5% nonfat dry milk,
0.1% Tween-20) for 1 h at room tem-
perature and then probed overnight at
4C with primary antibodies. The
presence of the primary antibodies was
detected by using horseradish peroxi-
dase-conjugated secondary antibody
and a chemiluminescence system
(SuperSignal West Pico Chemilumi-
nescent Substrate; Pierce, Rockford,
IL, USA). Digital images and quanti-
fication of the membranes were




A total of 5 · 104 periodontal ligament
cells were plated on six-well dishes and,
24 h later, the medium was changed to
0.2% fetal bovine serum-containing
medium and the cells were stimulated
with E. coli and A. actinomycetem-
comitans lipopolysaccharide for 72 h.
As preliminary experiments indicated a
similar ability of both E. coli and
A. actinomycetemcomitans lipopoly-
saccharide to induce RANKL mRNA
in periodontal ligament cells, as well as
in their capacity to support osteo-
clastogenesis, only lipopolysaccharide
from periopathogenic A. actinomyce-
temcomitans was used to stimulate the




added to the cocultures at 0 and 32 h.
Conditioned medium was removed at
72 h, the cell layer was washed with
phosphate-buffered saline twice and
then scraped off the wells and resus-
pended in 0.5 mL of fresh 0.2% fetal
bovine serum-containing medium.
A total of 3 · 104 cells were then
transferred to each well of a six-well
plate, which already contained RAW
264.7 cells (initial plating density:
5 · 104 cells/well), and cultured for
24 h. Then, 0.5 mL of conditioned
medium was added to the RAW 264.7
cells to determine the contribution of
soluble RANKL by the periodontal
ligament cells. RANKL (50 ng/mL)
and osteoprotegerin (100 ng/mL) were
used as controls for investigating the
capacity of RAW 264.7 cells to differ-
entiate into osteoclasts in response to
RANKL, as well as for studying the
ability of osteoprotegerin to block this
process. The cocultures were main-
tained for 6 d, with one change of
medium on day 3, and then submitted
to tartrate-resistant acid phosphate
(TRAP) staining (as described in
Technical Bulletin no. 445; BD Bio-
Sciences, Franklin Lakes, NJ, USA).
All reagents used for this assay were
from Sigma. Briefly, culture medium
was removed and the cells were washed
twice with phosphate-buffered saline.
The cells were then fixed with 10%
glutaraldehyde for 15 min (37C),
washed twice with prewarmed phos-
phate-buffered saline and stained for
5–10 min at 37C with the staining
buffer (50 mM sodium acetate buffer,
30 mM sodium tartrate, 0.1 mg/mL of
naphtol AS-MX phosphate, 0.1%
Triton X-100 and 0.3 mg/mL of Fast
Red Violet LB stain), pH 5.0. After
removal of the staining buffer, the cells
were washed three times with phos-
phate-buffered saline. These cells were
observed on an inverted microscope at
·40 magnification, depending on the
cell density, using bright field and the
numbers of stained cells containing
three or more nuclei were counted.
Statistical analysis
Pairwise comparisons between experi-
mental groups were performed using
the t-test with Welch’s correction
for unequal variances. Comparison
between fold changes on mRNA
expression between lipopolysaccharide-
stimulated and untreated cells was
performed with the one-sample t-test.
The significance level was set to 5% and
all calculations were performed using
PRISM 4 software (GraphPad, Inc., San
Diego, CA, USA).
Results
P38 MAPK regulates preferentially
RANKL mRNA expression in
lipopolysaccharide-stimulated
periodontal ligament cells
Preliminary experiments indicated that
the maximum expression of RANKL
mRNA occurred after 18–24 h of sti-
mulation with lipopolysaccharide from
either E. coli or A. actinomycetem-
comitans (Fig. 1A,B). The 18-h period
of lipopolysaccharide stimulation was
therefore chosen to enable the study of
lipopolysaccharide on RANKL gene
expression in periodontal ligament
cells. Semiquantitative RT-PCR indi-
cated that the inhibition of p38 MAPK
with SB203580 before stimulation with
lipopolysaccharide from E. coli or
A. actinomycetemcomitans resulted in a
significant decrease in the expression of
RANKL mRNA (Fig. 2A). Interest-
ingly, osteoprotegerin mRNA expres-
sion was not consistently affected by
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lipopolysaccharide stimulation and
also not significantly changed by
inhibiting p38 MAPK (Fig. 2B). Nev-
ertheless, the decrease of RANKL
expression achieved with SB203580
was of sufficient magnitude to reduce
the RANKL:osteoprotegerin ratio
(Fig. 2C). As it is this ratio that will
ultimately indicate the net effects on
osteoclast differentiation and activa-
tion, these results indicate that block-
ing p38 MAPK might impair
osteoclastogenesis induced by lipo-
polysaccharide-stimulated periodontal
ligament cells. However, in spite of
being significant, the lipopolysaccha-
ride-induced stimulation on RANKL
expression by periodontal ligament
cells was somewhat modest, represen-
ted by a 40% increase over the level
observed with unstimulated cells. On
the other hand, the decrease of
RANKL mRNA expression after
blocking p38 MAPK activity with
SB203580 was clear when E. coli lipo-
polysaccharide or A. actinomycetem-
comitans Y4 lipopolysaccharide was
used for stimulation.
RANKL protein expression induced
by lipopolysaccharide also requires
p38 MAPK activity
Expression of RANKL at the protein
level after stimulation with lipopoly-
saccharide from either E. coli or
A. actinomycetemcomitans confirmed
the importance of p38 MAPK, as
blocking this pathway with the bio-
chemical inhibitor SB203580 resulted
in a significant decrease of protein
expression (Fig. 3A,B). Also, protein
expression is probably indirect as we
could not find detectable levels of
RANKL after 24 or 48 h of stimu-
lation (data not shown). We were
also unable to detect RANKL
protein on concentrated cell culture
supernatants.
Lipopolysaccharide-stimulated
periodontal ligament cells support
osteoclastogenesis by membrane-
bound RANKL expression
Morphological changes (size and
multinucleation) and expression of
TRAP are indicative of terminal
osteoclast differentiation. The RAW
264.7 cell line is capable of differen-
tiation into osteoclasts in the presence
of exogenous RANKL (Figs 4A and
5) (32). The osteoclastogenesis assay
indicates the functionality of RANKL
produced by lipopolysaccharide-sti-
mulated periodontal ligament cells
(Fig. 5). The results mimicked the
findings for RANKL mRNA expres-
sion, as a significant (p < 0.05)
increase in the number of TRAP+
multinucleated cells was observed
after coculture with periodontal liga-
ment cells stimulated with lipopoly-
saccharide (Fig. 4B). A reduction in
the number of osteoclasts occurred
when osteoprotegerin (100 ng/mL)
was added to the cocultures, indica-
ting that osteoclast differentiation was
associated with RANKL expression
by periodontal ligament cells. This
decrease was significant (p < 0.05)
for E. coli lipopolysaccharide stimu-
lation, almost reaching statistical
significance (p ¼ 0.056) after A. actino-
A
B
Fig. 1. Time course of receptor activator of nuclear factor-jB ligand (RANKL) mRNA
expression induced by Escherichia coli and Aggregatibacter actinomycetemcomitans lipo-
polysaccharide in periodontal ligament cells. Reverse transcription-polymerase chain reac-
tion shows that RANKL mRNA expression induced by lipopolysaccharide is biphasic,
reaching an early peak after 4 h of stimulation and reached the maximum after 18–24 h
(A,B). E. coli lipopolysaccharide was a more potent inducer of osteoprotegerin expression
(A), which was already noticeable after 2 h of stimulation and remained essentially constant
throughout the 24-h period. A. actinomycetemcomitans Y4 lipopolysaccharide increased
osteoprotegerin mRNA modestly, and this effect was delayed, because it took 18 h of sti-
mulation to be more evident. Stimulation for periods longer than 24 h did not induce further
increases of either RANKL or osteoprotegerin mRNA expression (data not shown). Also, we
did not observe noticeable levels of RANKL mRNA expression by periodontal ligament cells
in the absence of any stimulation (data not shown). Representative images of three inde-
pendent experiments. Aa, Aggregatibacter actinomycetemcomitans; E. coli, Escherichia coli;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LPS, lipopolysaccharide; OPG,
osteoprotegerin.
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mycetemcomitans Y4 lipopolysaccha-
ride stimulation. As conditioned
medium from lipopolysaccharide-sti-
mulated periodontal ligament cells
had no effect on osteoclast formation
(data not shown), it is concluded that
residual lipopolysaccharide used for
stimulating the periodontal ligament
cells was not a confounding factor
and that lipopolysaccharide-stimula-
ted cells did not produce soluble
RANKL.
Inhibition of MKK3 and MKK6
decrease osteoclastogenesis
induced by lipopolysaccharide-
stimulated periodontal ligament cells
Coculture experiments using stable cell
lines over-expressing dominant-negat-
ive forms of upstream activators of p38
MAPK, MKK3 (MKK3 dominant
negative-periodontal ligament) and
MKK6 (MKK6 dominant negative -
periodontal ligament), resulted in a sig-
nificant (p < 0.05) decrease in the
number of TRAP+ cells in comparison
to a nontransformed murine periodon-
tal ligament cell line (Fig. 4C). This
indicates that upstream activators of
p38 MAPK are involved in lipopoly-
saccharide-induced RANKL expres-
sion by periodontal ligament cells.
Furthermore, MKK3 dominant nega-
tive-periodontal ligament and MKK6
dominant negative-periodontal liga-
ment had the same magnitude of effect
on the inhibition of osteoclast differen-
tiation, suggesting that both kinases are
important for lipopolysaccharide sign-
aling through the p38 MAPK pathway.
This finding might also suggest that the
a isoformof p38, which is activated only




In periodontal disease pathogenesis,
microbial virulence factors or micro-
bial-associated molecular patterns in-
duce an immune/inflammatory
response that will result in bone
resorption (33,34). Understanding the
molecular mechanisms involved in
coupled bone turnover can have a
profound impact on the development
of therapeutic approaches aiming at
the control of bone resorption associ-
ated with infections. Periodontal liga-
ment cells have been shown to express
RANKL in response to interleukin-1a,
interleukin-1b, A. actinomycetemcomi-
tans lipopolysaccharide, vitamin D3,
dexamethasone, prostaglandin E2 and
mechanical stress (10,15,16,35,36).
These findings illustrate the role of
periodontal ligament cells in alveolar
bone resorption; their relevance in
bone formation during periodontal
regenerative therapies is also well
established (37–40).
Osteoclast differentiation was shown
to be related to the activation of var-
ious intracellular signaling pathways,
including c-Jun N-terminal kinase, p38
and ERK MAPKs, as well as phos-
phoinositol-3-kinase and protein kin-
ase A pathways (41–43). However, the
role of different signaling pathways on
gene expression may differ according
to the nature of extracellular stimula-
tion, cell type and even cell differenti-
ation state (44). Supporting this
concept, bacterial-induced RANKL
expression by osteoblasts was found
not to require p38, ERK MAPKs or
the phosphoinositol-3-kinase pathway
(29), whereas p38 MAPK was recently
shown to regulate RANKL mRNA
and protein expression by osteoblasts
stimulated by adiponectin (45). In this
study we showed that p38 MAPK and
its upstream activators MKK3 and
MKK6 are required for lipopolysac-
charide-induced RANKL expression




Fig. 2. p38 mitogen-activated protein kin-
ase (MAPK) regulates preferentially recep-
tor activator of nuclear factor-jB ligand
(RANKL) in lipopolysaccharide-stimulated
periodontal ligament cells. Murine perio-
dontal ligament cells were grown to near
confluency and de-induced in medium con-
taining 0.3% fetal bovine serum for 8 h. The
specific inhibitor for p38MAPK (SB203580)
was added to the culture medium at 10 lM
30 min before the 18-h stimulation with
1 lg/mL of lipopolysaccharide from
Escherichia coli and Aggregatibacter actino-
mycetemcomitans lipopolysaccharide. Total
RNA was harvested and reverse transcrip-
tion-polymerase chain reaction was per-
formed and quantified using the GelDoc
System. The results indicate that the inhi-
bition of p38 MAPK reduced lipopoly-
saccharide-induced RANKL mRNA
expression, especially after E. coli lipopoly-
saccharide stimulation (A). No significant
regulation of osteoprotegerin mRNA
expression was observed following p38
inhibition (B). The decrease of RANKL
expression was sufficient to reduce the
RANKL:osteoprotegerin ratio (C). The fig-
ures are representative of three independent
experiments and bar graphs indicate mean
± standard deviation of normalized fold
changes of normalized gene expression.
*Indicates a significant difference (p < 0.05)
on mRNA expression in comparison to un-
stimulated cells. #Indicates a significant dif-
ference (p < 0.05) on mRNA expression in
comparison to lipopolysaccharide-treated
cells. Aa, Aggregatibacter actinomycetem-
comitans; E. coli, Escherichia coli; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase;
LPS, lipopolysaccharide; OPG, osteopro-
tegerin; SB, SB203580.
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over, the results of the osteoclastogen-
esis assays support a role for the
membrane-bound form of RANKL
expressed by these cells in response to
lipopolysaccharide stimulation.
We have previously shown that
lipopolysaccharide induces activation
of p38 MAPK in periodontal ligament
cells (3), and in this study we demon-
strated that inhibiting the p38 MAPK
pathway not only decreases lipopoly-
saccharide-induced RANKL expres-
sion but inhibits periodontal ligament
cell-induced osteoclastogenesis. It is
suggested that the decrease of RANKL
expression caused by inhibiting p38,
and the subsequent shift on the
RANKL:osteoprotegerin ratio, affects
the osteoclastogenesis process. These
results also agree with our previous
data regarding RANKL expression
and induction of osteoclastogenesis by
bone marrow stromal cells stimulated
with interleukin-1a and tumor necrosis
factor-a (3). Importantly, we have
also shown that the physiological cues
of coupled bone, namely vitamin D3
and parathyroid hormone, induced
RANKL expression and were not
affected by p38 inhibition. Other
investigators have reported decrea-
sed osteoclastogenesis induced by
RANKL-stimulated bone marrow-
derived cells with p38 inhibitors
(46,47), and recently all three MAPKs
were shown to be involved in interleu-
kin-1a-induced RANKL expression by
periodontal ligament fibroblasts (28).
As we evaluated only p38 MAPK,
we cannot rule out a significant role for
other signaling pathways in lipopoly-
saccharide-induced RANKL expres-
sion by periodontal ligament cells.
Nevertheless, further confirmation for
the role of the p38 MAPK pathway in
osteoclastogenesis supported by lipo-
polysaccharide-stimulated periodontal
ligament cells was provided in this
study by the use of genetic constructs
for over-expression of dominant-neg-
ative forms of MKK3 and MKK6,
upstream activators of p38 MAPK.
Interestingly, MKK3 and MKK6 were
recently shown to have differential
effects on osteoclast differentiation
induced by RANKL in bone marrow
stromal cells. Even though both
MKK3 and MKK6 were important for
p38 MAPK activation after RANKL
stimulation, only MKK6 played a role
in osteoclast differentiation induced by
RANKL in bone marrow cells (48).
Our finding of a similar role for MKK3
and MKK6 on osteoclast differenti-
ation supported by lipopolysaccharide-
stimulated periodontal ligament cells
probably reflects the role of both kin-
ases on RANKL expression by these
cells, whereas RANKL signaling in
osteoclast precursor cells may be
affected primarily by MKK6.
Collectively, this information sug-
gests that p38 signaling is important
not only for RANKL gene expression
but also for RANKL signaling. Regu-
lation of osteoprotegerin expression
seems to be more complex, as we
did not observe consistent changes
associated with either E. coli or A. ac-
tinomycetemcomitans Y4 lipopolysac-
charide stimulation. This agrees with
the findings of Tiranathanagul et al.
(36), who used human primary perio-
dontal ligament fibroblasts and a
noncommercial preparation of lipo-
polysaccharide from A. actinomyce-
temcomitans. Moreover, Okahashi
et al. (29) also did not report regula-
tion of osteoprotegerin mRNA
expression by osteoblasts after infec-
tion with P. gingivalis. On the other
hand, Lossdorfer et al. (11) have
shown increased osteoprotegerin
mRNA expression by periodontal
ligament cells after stimulation with
parathyroid hormone, whereas
RANKL mRNA expression was not
detected.
The results of the osteoclastogenesis
assay indicate that the increase of
RANKL expression induced by
lipopolysaccharide was of sufficient
A
B
Fig. 3. Receptor activator of nuclear factor-jB ligand (RANKL) protein expression by
lipopolysaccharide-stimulated periodontal ligament cells is dependent on p38 mitogen-acti-
vated protein kinase (MAPK) activity. Periodontal ligament cells grown on six-well plates
were de-induced for 12 h in culture medium containing 0.3% fetal bovine serum and were
then stimulated with lipopolysaccharide from either Escherichia coli or Aggregatibacter
actinomycetemcomitans for 72 h. The specific inhibitor for p38 MAPK (SB203580; 10 lM)
was added to the culture medium 30 min before stimulation with lipopolysaccharide
(1 lg/mL). (A) Western blot analysis of RANKL expression from periodontal ligament
whole-cell lysates. The positive control for RANKL expression is cell lysate from the human
prostate cancer cell line (PC-3). (B) Density analysis of data from three independent
experiments showed significant inhibition of lipopolysaccharide-induced RANKL protein by
SB203580 (*p < 0.05). Aa, Aggregatibacter actinomycetemcomitans; E. coli, Escherichia coli;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LPS, lipopolysaccharide.
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magnitude to alter the RANKL:oste-
oprotegerin ratio, shifting the bone
turnover towards resorption. This is in
spite of no significant changes in oste-
oprotegerin mRNA expression induced
by lipopolysaccharide in these cells.
However, the increase of osteoclast
numbers induced by lipopolysaccha-
ride-stimulated cells was somewhat
small (40 and 20% for E. coli and
A. actinomycetemcomitans Y4 lipo-
polysaccharide, respectively), parallel-
ing our findings for regulation of
RANKL expression at the mRNA and
protein levels. Yet, these results indi-
cate that periodontal ligament cells can
have relevant consequences on bone
turnover upon lipopolysaccharide sti-
mulation. Wada et al. (8) have shown
that unstimulated periodontal ligament
cells inhibit osteoclastogenesis and
attributed this effect to production of
osteoprotegerin. In this study we show
that the osteoclastogenesis induced by
lipopolysaccharide-stimulated perio-
dontal ligament cells can be attributed
to membrane-bound RANKL expres-
sion, as osteoprotegerin blocked this
effect completely and conditioned
medium from lipopolysaccharide-sti-
mulated cells did not induce osteo-
clastogenesis. This requirement of
direct cell-to-cell contact between
periodontal ligament and osteoclast




Fig. 4. Lipopolysaccharide-stimulated perio-
dontal ligament cells stimulate osteoclasto-
genesis, which is regulated by the p38
mitogen-activated protein kinase (MAPK)
pathway. (A) Stimulation with receptor
activator of nuclear factor-jB ligand
(RANKL) induces RAW 264.7 cells to dif-
ferentiate into multinucleated tartrate-
resistant acid phosphate (TRAP)+ cells,
whereas pretreatment with osteoprotegerin
inhibits this effect. *Indicates a significant
(p < 0.05) difference from unstimulated
cells and #indicates a significant decrease in
the number of osteoclasts with osteopro-
tegerin treatment. (B) Murine periodontal
ligament cells were stimulated with lipo-
polysaccharide from Escherichia coli and
Aggregatibacter actinomycetemcomitans Y4
and cultured for 3 d. These cells were then
cocultured with RAW 264.7 cells for an
additional 6 d and the number of multi-
nucleated TRAP+ cells was counted. Sti-
mulation with lipopolysaccharide increased
significantly the number of TRAP+ cells
and this effect was inhibited by osteopro-
tegerin *Indicates a significant (p < 0.05)
difference from unstimulated cells and
#indicates a significant decrease on the
number of osteoclasts with osteoprotegerin
treatment. !Indicates p ¼ 0.056 for the sig-
nificance of the decrease in the number of
osteoclasts with osteoprotegerin treatment
in A. actinomycetemcomitans Y4 lipopoly-
saccharide-stimulated cells. (C) Coculture of
RAW cells with stable periodontal ligament
cell lines over-expressing dominant-negative
mutants of MKK3 and of MKK6, upstream
activators of p38 MAPK, significantly
decreased the number of TRAP+ cells.
*Indicates a significant (p < 0.05) differ-
ence from nontransfected periodontal liga-
ment cells. Bar graphs indicate mean ±
standard deviation of the number of
TRAP+ multinucleated cells counted in
each well. Aa, Aggregatibacter actinomyce-
temcomitans; E. coli, Escherichia coli; LPS,
lipopolysaccharide; MKK3dn mPDL,
murine periodontal ligament cell line over-
expressing dominant-negative mutants of
MKK3; MKK6dn mPDL, murine perio-
dontal ligament cell line over-expressing
dominant-negative mutants of MKK6;
OPG, osteoprotegerin.
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Kanzaki et al. (14); however, they did
not use any extracellular stimulation to
induce RANKL expression. There are
other important methodological dif-
ferences in the osteoclastogenesis
model used that may account for dif-
ferences between our results and those
of others (17), including the nature of
stimulation used to induce RANKL
(mechanical compression vs. lipopoly-
saccharide), the osteoclast precursor
cells used (peripheral blood monocytes
vs. monocytic/macrophage cell line)
and the time of coculture (3 wk vs. 5–
6 d). In our model, by scraping off the
periodontal ligament cells after stimu-
lation with lipopolysaccharide we were
able to adjust the number of cells pla-
ted onto the precursor cells to avoid
influences on cell proliferation that the
lipopolysaccharide stimulation might
have had on the periodontal ligament
cells.
Our findings on the osteoclastogen-
esis assay are contrary to a report in
which lipopolysaccharide-stimulated
periodontal ligament cells did not
induce osteoclast formation in a
coculture with precursor cells (49).
This might be because of the different
experimental models used. We used a
continuous lineage of mouse perio-
dontal ligament cells, whereas Wada
et al. (49) used primary human perio-
dontal ligament cells. In the primary
cells, osteoprotegerin expression was
shown to be more affected than
RANKL after lipopolysaccharide sti-
mulation. Moreover, significant vari-
ability was shown at the level of basal
and stimulated RANKL expression
among the primary periodontal liga-
ment cells, which might be responsible
for the striking differences between
the results of Wada et al. (49) and
those of Tiranathanagul et al. (36),
who reported increased RANKL
expression induced by A. actinomyce-
temcomitans lipopolysaccharide in pri-
mary periodontal ligament fibroblasts,
whereas osteoprotegerin expression
was not affected. Also note that we
experienced some variability in osteo-
clastogenesis assays where periodontal
ligament cells cultured with RAW
macrophages resulted in osteoclast
formation on occasion. These data
may be a result of the passage number
with the RAW cells, rather than the
periodontal ligament cell line. Despite
this experimental baseline difference,
significant stimulation of TRAP-posit-
ive multinucleated cells with lipopoly-
saccharide was observed. Interestingly,
the periodontal ligament cells and
gingival fibroblasts seem to have con-
trasting responses to lipopolysaccha-
ride regarding osteoclastogenesis, as
Nagasawa et al. (50) have shown
increased expression of osteoprotegerin
(and not RANKL) mRNA. Cell cul-
ture supernatants of lipopolysaccha-
ride-stimulated gingival fibroblasts
also inhibited differentiation of pre-
cursor hematopoietic cells in response
to RANKL stimulation. It is import-
ant to note that the biochemical com-
position of purified lipopolysaccharide
may influence the results and explain
some of the conflicting results in
the literature. Even though we evalu-
ated our A. actinomycetemcomitans Y4
lipopolysaccharide preparation to
ensure that it was not contaminated by
nucleic acid or protein, the lower limits
of detection of the procedures cannot
absolutely rule out minor protein
contamination.
Recent in vivo data from our labor-
atory group support the role of p38
signaling which is required for perio-
dontal bone loss in an experimental rat
model (3). In this model, A. actin-
omycetemcomitans lipopolysaccharide-
induced alveolar bone loss was blocked
by an orally active p38 inhibitor.
Reduced numbers of osteoclasts were








Fig. 5. RAW 264.7 differentiated into tartrate-resistant acid phosphate (TRAP)+ multi-
nucleated osteoclastic-like cells in response to exogenous receptor activator of nuclear factor-
jB ligand (RANKL) or coculture with lipopolysaccharide-stimulated periodontal ligament
cells. The top panel depicts RAW 264.7 cells only (5 · 104) cultured for 6 d without or with
RANKL (50 ng/mL) and RANKL/osteoprotegerin (100 ng/mL). The middle panel shows
the results of coculture experiments where vehicle control or lipopolysaccharide (1 lg/mL)-
treated murine periodontal ligament cells were stimulated for 72 h, then 5 · 104 cells were
added to each well containing 5 · 104 RAW 264.7 cells. Cocultures were maintained for 6 d,
both in the presence and absence of osteoprotegerin (100 ng/mL) (right panels). All images
are representative of three independent experiments. A.a, Aggregatibacter actinomycetem-
comitans; E. coli, Escherichia coli; LPS, lipopolysaccharide; OPG, osteoprotegerin; PDL,
periodontal ligament.
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bone resorption, including the perio-
dontal ligament area. Other recent
studies have suggested that T- and
B-cell-derived RANKL are the pre-
dominant sources of RANKL in
human periodontal diseased tissue
compared with healthy sites (22).
However, this study utilized only
biopsied soft tissue, which did not
include the periodontal ligament or
associated bony tissue from diseased
sites. Recently, Taubman et al. (20)
discussed the relevance of immune
cells, specifically B and T cells, to bone
resorption in periodontal disease.
Although the role of B and T cells in
bone resorption is compelling, it is not
possible to rule out the role of resident
cells, such as endothelial cells of perio-
dontal ligament fibroblasts, in bone
resorption, because they are also cap-
able of expressing functional RANKL.
In the complexity of the in vivo host
response to the antigens from the sub-
gingival biofilm, it is more than likely
that cytokines, chemokines and growth
factors produced by resident cells will
play a role in the network of events
that ultimately can modulate the
activity of immune cells. As evidence
supporting this assumption, A. actino-
mycetemcomitans infection was shown
to induce bone loss in severe combined
immunodeficiency mice. Even though
this bone loss was approximately half
of that observed in severe combined
immunodeficiency mice transplanted
with T cells from humans with
aggressive periodontitis, it was signifi-
cantly greater than found in sham-
infected control severe combined
immunodeficiency mice (19). Thus, the
periodontal ligament may still play a
prominent source of local RANKL
production within the periodontal
microenvironment, especially when
one considers the dynamics of the
homeostasis of the periodontal liga-
ment and the role of the cells in this
tissue to regulate alveolar bone turn-
over. These findings suggest that p38
signaling plays a major role in con-
trolling cytokine expression in the
periodontal ligament, which can
contribute towards inflammatory
bone loss associated with periodontal
diseases.
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